NASDAQ:DCOY | Free Cash Flow | Decoy Therapeutics Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2015-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$2.89M
2025-12-31-$1.14M
2025-03-31-$1.18M
2024-12-31-$742,518.00
2024-03-31-$1.35M
2023-12-31-$1.51M
2023-03-31-$3.17M
2022-12-31-$4.71M
2022-03-31-$3.52M
2021-12-31-$2.72M
2021-03-31-$2.72M
2020-12-31-$1.37M
2020-03-31-$3.71M
2019-12-31-$2.64M
2019-03-31-$2.66M
2018-12-31$387,538.00$0.00$387,538.00
2018-03-31-$9.41M$0.00-$9.41M
2017-12-31-$5.76M$15,398.00-$5.77M
2017-03-31-$8.23M$22,150.00-$8.25M
2016-12-31-$6.3M$50,391.00-$6.35M
2016-03-31-$9.17M$107,286.00-$9.28M
2015-12-31-$5.44M$42,352.00-$5.48M
2015-03-31-$4.14M$26,395.00-$4.17M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$4.83M
2024-12-31-$4.53M
2023-12-31-$12.85M
2022-12-31-$17.6M
2021-12-31-$10.2M$0.00-$10.2M
2020-12-31-$10.31M$2,600.00-$10.31M
2019-12-31-$11.58M$0.00-$11.58M
2018-12-31$4.18M$0.00$4.18M
2017-12-31-$27.72M$113,498.00-$27.84M
2016-12-31-$32.05M$559,378.00-$32.61M
2015-12-31-$20.75M$265,617.00-$21.01M